Next Article in Journal
Interplay between Energy Supply and Glutamate Toxicity in the Primary Cortical Culture
Previous Article in Journal
A Tiny Viral Protein, SARS-CoV-2-ORF7b: Functional Molecular Mechanisms
Previous Article in Special Issue
Bottlenecks in the Investigation of Retinal Sterol Homeostasis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 14
Issue 5
10.3390/biom14050542
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis of a Side Chain Alkyne Analogue of Sitosterol as a Chemical Probe for Imaging in Plant Cells

by
Miriam Hollweck
,
David Jordan
and
Franz Bracher
*
Department of Pharmacy, Ludwig-Maximilians University Munich, Butenandtstraße 5–13, 81377 Munich, Germany
*
Author to whom correspondence should be addressed.
Biomolecules 2024, 14(5), 542; https://doi.org/10.3390/biom14050542
Submission received: 11 April 2024 / Revised: 23 April 2024 / Accepted: 29 April 2024 / Published: 30 April 2024
(This article belongs to the Special Issue Sterol Biosynthesis and Function in Organisms)
Browse Figures
Versions Notes

Abstract

:
Clickable chemical tools are essential for studying the localization and role of biomolecules in living cells. For this purpose, alkyne-based close analogs of the respective biomolecules are of outstanding interest. Here, in the field of phytosterols, we present the first alkyne derivative of sitosterol, which fulfills the crucial requirements for such a chemical tool as follows: very similar in size and lipophilicity to the plant phytosterols, and correct absolute configuration at C-24. The alkyne sitosterol FB-DJ-1 was synthesized, starting from stigmasterol, which comprised nine steps, utilizing a novel alkyne activation method, a Johnson–Claisen rearrangement for the stereoselective construction of a branched sterol side chain, and a Bestmann–Ohira reaction for the generation of the alkyne moiety.

1. Introduction

Steroidal compounds are widespread in higher living organisms, as exemplified by cholesterol, as well as metabolically derived steroid hormones in eukariotic cells [1], ergosterol as an essential cell membrane component in fungi (and its biosynthesis as one of the major targets of antifungals [2]), and phytosterols in plants. Phytosterols exhibit numerous important functions in plant cells [3], and numerous beneficial pharmacological activities have been described for them [4].
Nevertheless, the biosynthesis, cellular localization, and metabolism of phytosterols is still the subject of many in-depth investigations. One important methodology in this field is the microscopic imaging of sterols in living cells. In the end, this approach uses fluorescent derivatives of the relevant sterols, obtained by the coupling of appropriately substituted steroidal chemical tools with tailored fluorescent dyes [5].
At present, the most important approach for imaging small molecules (physiological substances, natural products, drug candidates) in cells utilizes “click chemistry”. This chemical ligation technology was defined first by K. B. Sharpless in 2001 [6], and he was (together with C. Bertozzi and M. Meldal) awarded with the Nobel Prize in Chemistry “for the development of click chemistry and bioorthogonal chemistry” in 2022.
Click chemistry is among the bio-orthogonal methods [7], meaning chemical reactions that can occur inside of living organisms without (too much) interfering with the native biochemical processes [8]. Among the most important click reactions is the 1,3-dipolar cycloaddition between organic azides and alkynes, performed as copper-catalyzed azide-alkyne cycloaddition (CuAAC) [9], or as strain-promoted azide-alkyne cycloaddition (SPAAC) [10].
Click chemistry has meanwhile found ample applications in steroid chemistry, with applications in organic synthesis, material science, drug discovery, and bioconjugation chemistry [9,11]. Recently, CuAAC has also been combined with photo-crosslinking (“PhotoClick cholesterol”) for the identification of sterol-binding proteins in yeast cells by means of quantitative proteomics [12].
Clickable steroids for biochemical investigations have, up to now, been developed mainly for cholesterol; exceptions include a lanosterol side chain alkyne [13] and several side chain alkyne derivatives of cholesterol (1) biosynthesis intermediates (a-Chol, a-7-DHC, a-DHCEp) [14] from the Porter lab. Only one cholesterol side chain alkyne with a complete isooctyl side chain has been published [15]; complementary clickable cholesterol azides are only published with truncated side chains [16,17]. A couple of clickable steroids have been derived from cholesterol (1) and bile acids via the functionalization of the 3-hydroxy group by means of etherification or esterification with short-chain alkynes [18,19,20] or azides [19,20]. However, this modification suffers from the elimination of the physiologically important hydroxy group in the sterols, resulting in the significantly changed lipophilicity of the tools, and, in the case of esters, unpredictable hydrolytic stability in living cells. Based on such considerations, the Salic group attached an alkyne functionality at C-19 in cholesterol (1) [5].
In contrast to cholesterol (1), phytosterols, like sitosterol (2) and stigmasterol, have a more complex side chain at C-17, with a typical ethyl branching, resulting in a 24α-configured additional stereocenter. Sterols with 24β-configuration, like clionasterol (3) and poriferasterol, are rather found in algae [21] (Figure 1).
Until now, clickable sitosterol (2) derivatives have only been obtained via the etherification of 3-OH with a propargyl residue [22] and by the conversion of the 3β-configured secondary alcohol into a 3α-azide [23]. A related side chain azide has only been derived from diosgenin [24].
In the present project, we aimed at developing a clickable sitosterol alkyne (FB-DJ-1, 4) with the alkyne group at the terminus of the side chain, and with the correct 24α configuration (Figure 1). By converting one of the two methyl groups of the terminal isopropyl moiety into an ethynyl unit, neither the size nor lipophilicity of the original phytosterol should be drastically altered, so we expect that this new chemical tool should perfectly mimic sitosterol in its biological behavior, especially distribution in living organisms. This modification will, however, generate a new stereocenter at C-25. Since which configuration at C-25 would be advantageous in cells was unpredictable, we decided to synthesize the target sitosterol alkyne FB-DJ-1 (4) as an epimeric mixture with 24R,25RS configuration.

2. Materials and Methods

1H and 13C NMR spectra were recorded with either Avance III HD 400 MHz Bruker BioSpin or Avance III HD 500 MHz Bruker BioSpin spectrometers (Bruker Bio-Spin, Billerica, MA, USA). Chemical shifts are given in parts per million (ppm). J values are given in Hertz (Hz). Standard abbreviations are used to denote multiplicities. Signal assignments were carried out based on 1H, 13C, HMBC, HSQC, and COSY spectra. EI mass spectra were recorded on a Jeol Mstation 700 or JMS GCmate II Jeol (Jeol, Tokyo, Japan). Purification via flash column chromatography was performed using Silica Gel 60 (Merck, Darmstadt, Germany). All reactions were monitored with TLC using precoated plastic sheets POLYGRAM from Macherey-Nagel (Düren, Germany). Detection was either carried out using the CAM stain (ceric ammonium molybdate) followed by heating, or UV light at 254 nm. The melting points were determined using a Büchi Melting Point B-540 device (Büchi Labortechnik AG, Flawil, Switzerland). Optical rotation was measured using a 241 MC polarimeter from Perkin Elmer (Waltham, MA, USA). All measurements were carried at room temperature in CHCl3; the concentrations are given in g/100 mL. HPLC purities were determined using an Agilent G1311A QuatPump with a G1315C DAD SL detector (210 nm); column: Zorbax C18 SB (3.5 µm), eluent: methanol, phosphate buffer pH 5 (99:1), temperature 50 °C, flow rate: 1 mL/min.
(22R)-6β-Methoxy-3α,5-cyclo-27-nor-5α-cholest-23-yn-22-ol (9a) and
(22S)-6β-Methoxy-3α,5-cyclo-27-nor-5α-cholest-23-yn-22-ol (9b)
To a stirred solution of but-1-yn-1-yltrimethylsilane (8; 3.3 mL, 19 mmol) and TBAF (1 M in THF, 0.97 mL, 0.97 mmol) in dry THF (50 mL) under nitrogen atmosphere, a solution of (20S)-6β-methoxy-3α,5-cyclo-5α-pregnane-20-carboxaldehyde (7) (1.7 g, 4.8 mmol) in dry THF (40 mL) was added dropwise over the course of 30 min. The reaction mixture was stirred for another 15 min, then hydrochloric acid (1 M, 1.0 mL) was added and stirring continued for 15 min. The mixture was neutralized with an aqueous NaHCO3 solution, and the biphasic mixture was extracted with ethyl acetate (3 × 100 mL). The combined organic extracts were dried using a phase separation paper, and the solvent was removed in vacuo. The crude product was subjected to column chromatography (isohexanes/ethyl acetate 95:5) to first provide (22R)-6β-methoxy-3α,5-cyclo-27-nor-5α-cholest-23-yn-22-ol (9a) (0.36 g, 0.91 mmol, 19%) as a colorless solid, and then (22S)-6β-methoxy-3α,5-cyclo-27-nor-5α-cholest-23-yn-22-ol (9b) (0.67 g, 1.7 mmol, 35%) as a colorless oil.
9a: 1H NMR (500 MHz, DMSO) δ 4.87 (d, J = 5.2 Hz, 1H, 22-OH), 4.37–4.30 (m, 1H, H-22), 3.21 (s, 3H, OCH3), 2.73 (t, J = 2.8 Hz, 1H, H-6), 2.17 (qd, J = 7.5, 1.9 Hz, 2H, C-25), 1.84–1.23 (m, 13H), 1.17–0.98 (m, 7H), 0.95 (s, 3H, H-19), 0.90 (d, J = 6.2 Hz, 3H, H-21), 0.87–0.75 (m, 3H, H-1, H-3 and H-9), 0.63 (s, 3H, H-18), 0.59 (t, J = 4.3 Hz, 1H, H-4), 0.40 (dd, J = 8.0, 4.9 Hz, 1H, H-4). 13C NMR (126 MHz, DMSO) δ 84.7 (C, C-23), 82.3 (C, C-24), 81.2 (CH, C-6), 62.9 (C, C-22), 55.9 (CH3, OCH3), 55.6 (CH, C-14), 50.4 (CH, C-17), 47.5 (CH, C-9), 43.0 (C, C-10), 42.2 (C, C-13), 40.3 (CH, C-20), 38.7 (CH2, C-12), 34.9 (C, C-5), 34.8 (CH2, C-7), 32.8 (CH2, C-1), 30.0 (CH, C-8), 26.3 (CH2, C-16), 24.6 (CH2, C-2), 23.8 (CH2, C-15), 22.2 (CH2, C-11), 20.8 (CH, C-3), 19.3 (CH3, C-19), 14.0 (CH3, C-26), 13.7 (CH3, C-21), 12.8 (CH2, C-4), 12.5 (CH2, C-25), 11.7 (CH3, C-18). HREIMS m/z 398.3179 (calcd for [C27H42O2]•+, 398.3179). m.p.: 133 °C, [α] = −9.5° (c = 0.11)
9b: 1H NMR (500 MHz, DMSO) δ 4.84 (d, J = 5.5 Hz, 1H, 22-OH), 4.24 (dq, J = 5.4, 1.9 Hz, 1H, H-22), 3.21 (s, 3H, OCH3), 2.75–2.71 (m, 1H, H-6), 2.17 (qd, J = 7.5, 1.9 Hz, 2H, C-25), 1.90 (dt, J = 12.5, 3.4 Hz, 1H, C-12), 1.84–1.22 (m, 12H), 1.13–0.98 (m, 10H), 0.95 (s, 3H, H-19), 0.89 (dd, J = 8.0, 4.0 Hz, 1H, H-3), 0.85–0.76 (m, 2H, H-1 and H-9), 0.65 (s, 3H, H-18), 0.59 (t, J = 4.3 Hz, 1H, H-4), 0.40 (dd, J = 7.9, 4.9 Hz, 1H, H-4). 13C NMR (126 MHz, DMSO) δ 84.7 (C, C-23), 82.4 (C, C-24), 81.2 (CH, C-6), 63.2 (C, C-22), 55.9 (CH3, OCH3), 55.8 (CH, C-14), 51.4 (CH, C-17), 47.2 (CH, C-9), 42.9 (C, C-10), 42.3 (C, C-13), 42.0 (CH, C-20), 39.3 (CH2, C-12, underneath the solvent signal), 34.9 (C, C-5), 34.8 (CH2, C-7), 32.8 (CH2, C-1), 30.1 (CH, C-8), 27.0 (CH2, C-16), 24.6 (CH2, C-2), 23.8 (CH2, C-15), 22.3 (CH2, C-11), 20.8 (CH, C-3), 19.3 (CH3, C-19), 14.0 (CH3, C-26), 13.5 (CH3, C-21), 12.8 (CH2, C-4), 12.0 (CH2, C-25), 11.7 (CH3, C-18). HREIMS m/z 398.3180 (calcd for [C27H42O2]•+, 398.3179).
(22R,23Z)-6β-Methoxy-3α,5-cyclo-27-nor-5α-cholest-23-en-22-ol (10a)
This compound was synthesized from alkynol 9a (0.17 g, 0.43 mmol) via catalytic hydrogenation using Lindlar’s catalyst, according to procedure from the literature [25], providing 10a as a colorless sticky oil (96 mg, 0.24 mmol, 56%). 1H NMR (500 MHz, CDCl3) δ 5.50–5.38 (m, 2H, H-23 and H-24), 4.69–4.64 (m, 1H, H-22), 3.33 (s, 3H, OCH3), 2.78 (t, J = 2.9 Hz, 1H, H-6), 2.19–2.00 (m, 2H, H-25), 1.94 (ddt, J = 37.0, 13.6, 3.3 Hz, 2H, H-1 and H-12), 1.80–1.57 (m, 4H), 1.54–1.23 (m, 8H), 1.17–1.06 (m, 3H), 1.03 (s, 3H, H-19), 1.00 (t, J = 7.5 Hz, 3H, H-26), 0.90–0.83 (m, 7H), 0.76 (s, 3H, H-18), 0.65 (dd, J = 5.1, 3.8 Hz, 1H, H-4), 0.44 (dd, J = 8.0, 5.1 Hz, 1H, H-4). 13C NMR (126 MHz, CDCl3) δ 133.1 (CH, C-23 or C-24), 131. (CH, C-23 or C-24)C, 82.6 (CH, C-6), 69.5 (CH, C-22), 56.8 (CH3, OCH3), 56.4 (CH, C-14), 51.9 (CH, C-17), 48.3 (CH, C-9), 43.6 (C, C-10), 42.9 (C, C-13), 40.7 (CH, C-20), 39.8 (CH2, C-12), 35.4 (C, C-5), 35.2 (CH2, C-1), 33.5 (CH2, C-7), 30.6 (CH, C-8), 27.2 (CH2, C-16), 25.1 (CH2, C-2), 24.2 (CH2, C-15), 22.9 (CH2, C-11), 21.6 (CH, C-3), 21.5 (CH2, C-25), 19.4 (CH3, C-19), 14.5 (CH3, C-26), 13.2 (CH2, C-4), 13.1 (CH3, C-18), 12.5 (CH3, C-21). HREIMS m/z 400.3330 (calcd for [C27H44O2]•+, 400.3336).
(22R,23E)-6β-Methoxy-3α,5-cyclo-27-nor-5α-cholest-23-en-22-ol (10b)
In a flame-dried Schlenk flask, LiAlH4 (0.51 g, 13 mmol) was suspended in dry THF (30 mL) under a nitrogen atmosphere. A solution of (22S)-6β-methoxy-3α,5-cyclo-27-nor-5α-cholest-23-yn-22-ol (9b) (0.67 g, 1.7 mmol) in dry THF (25 mL) was added, and the mixture was stirred overnight under reflux. After cooling to room temperature, the reaction was quenched by the addition of hydrochloric acid (1 M, 20 mL) and brine (20 mL), then was extracted with DCM (3 × 50 mL). The combined organic extracts were dried with a phase separation paper, and the solvent was removed in vacuo. Purification via column chromatography (isohexanes/ethyl acetate 90:10) provided (22R,23E)-6β-methoxy-3α,5-cyclo-27-nor-5α-cholest-23-en-22-ol (10b) (0.48 g, 1.2 mmol, 72%) as a colorless solid. 1H NMR (400 MHz, CDCl3) δ 5.66 (dtd, J = 15.5, 6.2, 1.4 Hz, 1H, H-24), 5.49 (ddt, J = 15.5, 5.3, 1.5 Hz, 1H, H-2′), 4.21 (t, J = 5.4 Hz, 1H, H-22), 3.33 (s, 3H, OCH3), 2.77 (t, J = 2.9 Hz, 1H, H-6), 2.12–2.02 (m, 2H, H-4′), 1.93 (ddt, J = 26.2, 13.6, 3.3 Hz, 3H, H-12 and CH2), 1.83–1.59 (m, 3H, H-8 and CH2), 1.55–1.30 (m, 7H), 1.21–0.98 (m, 10H), 0.93–0.78 (m, 6H, H-3, H-9, H-21 and CH2), 0.73 (s, 3H, H-18), 0.67–0.62 (m, 1H, H-4), 0.43 (dd, J = 8.0, 5.1 Hz, 1H, H-4). 13C NMR (101 MHz, CDCl3) δ 132.5 (CH, C-24), 131.7 (CH, C-23), 82.6 (CH, C-6), 74.3 (CH, C-22), 56.7 (CH3, OCH3), 56.5 (CH, C-14), 52.8 (CH, C-17), 48.1 (CH, C-9), 43.5 (C, C-10), 42.9 (CH2,C-13), 41.6 (CH, C-20), 40.4 (CH2, C-12), 35.4 (C, C-5), 35.2 (CH2), 33.5 (CH2), 30.7 (CH, C-8), 28.0 (CH2), 25.5 (CH2), 25.1 (CH2, C-25), 24.4 (CH2), 22.9 (CH2), 21.7 (CH, C-3), 19.4 (CH3, C-19), 13.8 (CH3, C-26), 13.2 (CH2, C-4), 12.4 (CH3, C-21), 12.1 (CH3, C-18). HREIMS m/z 400.3331 (calcd for [C27H44O2]•+, 400.3336). m.p.: 135 °C. [α] = 26.6° (c = 0.23).
Ethyl (22E,24R,25RS)-6β-Methoxy-3α,5-cyclo-5α-stigmast-22-en-26-oate (11)
To a solution of (22R,23E)-6β-ethoxy-3α,5-cyclo-27-nor-5α-cholest-23-en-22-ol (10b) (0.48 g, 1.2 mmol) in xylene (45 mL), triethyl orthopropionate (3.8 mL, 19 mmol) and propionic acid (89 µL, 1.2 mmol) were added under a nitrogen atmosphere, and the mixture was heated to reflux for 1.25 h. After cooling to room temperature, saturated Na2CO3 solution (50 mL) was added, and the biphasic mixture was extracted with ethyl acetate (3 × 50 mL). The combined organic extracts were washed with water (2 × 100 mL) and brine (100 mL), and then dried using a phase separation paper. After the solvent had been removed in vacuo, the crude product was subjected to column chromatography (isohexanes/ethyl acetate 95:5) to provide ethyl (22E,24R,25RS)-6β-methoxy-3α,5-cyclo-5α-stigmast-22-en-26-oate (11) (0.45 g, 0.93 mmol, 78%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 5.29–5.19 (m, 1H, H-22), 5.08 (dd, J = 15.1, 9.2 Hz, 0.46H, H-23), 4.95 (dd, J = 15.1, 9.4 Hz, 0.61H, H-23), 4.17–4.03 (m, 2H, H-1′), 3.32 (d, J = 0.7 Hz, 3H, OCH3), 2.77 (t, J = 2.4 Hz, 1H, H-6), 2.40–2.28 (m, 1H, H-2′), 2.14–1.57 (m, 8H), 1.53–0.96 (m, 24H), 0.90–0.79 (m, 6H, H-1, H-3, H-9 and H-29), 0.72 (d, J = 2.6 Hz, 3H, H-18), 0.65 (t, J = 4.4 Hz, 1H, H-4), 0.43 (dd, J = 8.0, 5.0 Hz, 1H, H-4). 13C NMR (101 MHz, CDCl3) δ 176.6 and 176.0 (C, C-26), 140.2 and 139.4 (CH, C-22), 128.6 and 127.9 (CH, C-23), 82. (CH, C-6), 60.2 and 60.0 (CH2, C-1′), 56.8 and 56.7 (CH, C-14), 56.0 (CH3, OCH3), 48.2 (CH, C-9), 48.1 (CH, C-17), 47.9 (CH, C-24), 44.6 and 44.4 (CH3, C-2′), 43.6 (C, C-10), 42.9 (C, C-13), 40.6 and 40.5 (CH, C-20), 40.3 (CH2, C-12), 35.4 (C, C-5), 35.2 (CH2, C-7), 33.5 (CH2, C-1), 30.6 (CH, C-8), 29.0 and 29.0 (CH2, C-15), 26.3 (CH2, C-11), 25.1 and 24.8 (CH2, C-2), 24.4 (CH2, C-16), 22.9 (CH2, C-28), 21.6 (CH, C-3), 21.2 and 21.1 (CH3, C-21), 19.4 (CH3, C-19), 14.8 (CH3, C-2′), 14.5 and 14.4 (CH3, C-27), 13.2 (CH2, C-4), 12.6 (CH3, C-18), 12.3 and 12.1 (CH3, C-29). HREIMS m/z 484.3911 (calcd for [C32H52O3]•+, 484.3910).
Ethyl (24R,25RS)-6β-Methoxy-3α,5-cyclo-5α-stigmastan-26-oate (12)
This compound was synthesized from Δ22 analogue 11 (0.45 g, 0.93 mmol) via catalytic hydrogenation using Pd on a charcoal catalyst, according to a procedure from the literature [26] as follows: yield: 0.40 g, 0.82 mmol, 88%. 1H NMR (500 MHz, CDCl3) δ 4.10–4.01 (m, 2H, H-1′), 3.25 (s, 3H, OCH3), 2.76–2.65 (m, 1H, H-6), 2.48–2.35 (m, 1H, H-25), 1.93–1.53 (m, 5H), 1.48–0.71 (m, 37H), 0.64 (d, J = 3.1 Hz, 3H, H-18), 0.60–0.56 (t, J = 4.4 Hz, 1H, H-4), 0.36 (dd, J = 8.0, 5.1 Hz, 1H, H-4). 13C NMR (126 MHz, CDCl3) δ 177.0 and 176.9 (C, C-26), 82.6 (CH, C-6), 60.1 (CH2, C-1′), 56.7 (CH3, OCH3), 56.67 and 56.65 (CH, C-14), 56.3 and 56.2 (CH, C-17), 48.2 (CH, C-9), 43.5 (C, C-10), 42.93 and 42.92 (C, C-13), 42.91 and 42.41 (CH, C-24), 41.7 and, 41.6 (CH, C-25), 40.43 and 40.40 (CH2, C-12), 36.4 and 36.2 (CH, C-20), 35.4 (C, C-5), 35.2 (CH2, C-1), 33.5 (CH2, C-7), 33.3 and 33.0 (CH2, C-22), 30.6 (CH, C-8), 28.5 and 28.4 (CH2, C-16), 27.3 (CH2, C-2), 26.2 (CH2, C-23), 25.1 (CH2, C-15), 24.4 and 24.3 (CH2, C-11), 23.0 and 22.9 (CH2, C-28), 21.7 (CH, C-3), 19.4 (CH3, C-19), 18.93 and 18.86 (CH3, C-21), 14.5 (CH3, C-2′), 13.2 and 13.0 (CH2, C-4), 12.5 and, 12.4 (CH3, C-27), 11.9 (CH3, C-18), 11.5 (CH3, C-29). HREIMS m/z 486.4068 (calcd for [C32H54O3]•+, 486.4064).
(24R,25RS)-6β-Methoxy-3α,5-cyclo-5α-stigmastan-26-ol (13)
To a stirred suspension of LiAlH4 (0.30 g, 8.0 mmol) in dry THF (30 mL) under nitrogen atmosphere, a solution of ethyl ester 12 (0.39 g, 0.80 mmol) in dry THF (20 mL) was added, and the mixture was stirred over night at room temperature. After the addition of the saturated aqueous NH4Cl solution (40 mL), the biphasic mixture was extracted with ethyl acetate (3 × 50 mL). The combined organic extracts were subsequently washed with water (2 × 100 mL) and brine (100 mL). After drying using a phase separation paper, the solvent was evaporated and the crude product was subjected to column chromatography (isohexanes/ethyl acetate 90:10) to provide (24R,25RS)-6β-methoxy-3α,5-cyclo-5α-stigmastan-26-ol (13) (0.34 g, 0.77 mmol, 96%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 3.64–3.54 (m, 1H, H-26), 3.50–3.41 (m, 1H, H-26), 3.32 (s, 3H, OCH3), 2.77 (t, J = 2.9 Hz, 1H, H-6), 1.98 (dq, J = 12.5, 3.5 Hz, 1H, H-12), 1.89 (dt, J = 13.6, 3.2 Hz, 1H, H-7), 1.86–1.60 (m, 4H, H-8, H-25 and CH2), 1.51 (dt, J = 13.8, 7.9 Hz, 2H, CH2), 1.43–0.78 (m, 29H, with s, 3H, H-19 underneath), 0.71 (d, J = 1.9 Hz, 3H, H-18), 0.65 (t, J = 4.4 Hz, 1H, H-4), 0.43 (dd, J = 8.0, 5.1 Hz, 1H, H-4). 13C NMR (126 MHz, CDCl3) δ 82.6 (CH, C-6), 67.0 and 66.8 (CH2, C-26), 56.71 (CH3, OCH3), 56.67 and 56.66 (CH, C-14), 56.4 and 56.3 (CH, C-17), 48.2 (CH, C-9), 43.5 (C, C-7), 42.94 and 42.92 (C, C-13), 41.9 and 41.4 (CH, C-24), 40.5 and 40.4 (CH2,C-12), 37.51 and 37.49 (CH, C-25), 36.5 and 36.3 (CH, C-20), 35.5 (C, C-10), 35.2 (CH2, C-16), 34.2 and 33.9 (CH2, C-1), 33.5 (CH2, C-22), 30.6 (CH, C-8), 28.52 and 28.50 (CH2), 27.1 (CH2), 26.1 (CH2), 25.1 (CH2), 24.3 and 24.2 (CH2), 22.9 and 22.6 (CH2, C-11), 21.7 (CH, C-3), 19.4 (CH3, C-21), 19.0 and 18.9 (CH3, C-19), 13.2 (CH2, C-4), 13.1 (CH3, C-29), 12.54 and 12.45 (CH3, C-27), 12.4 (CH3, C-18). HREIMS m/z 444.3965 (calcd for [C30H52O2]•+, 444.3962).
(24R,25RS)-26-Ethynyl-6β-methoxy-26-nor-3α,5-cyclo-5α-stigmastane (15)
To a solution of (24R,25RS)-6β-methoxy-3α,5-cyclo-5α-stigmastan-26-ol (13) (0.33 g, 0.76 mmol) in dichloromethane (10 mL), PCC (0.33 g, 1.5 mmol) was added, and the mixture was stirred for 4 h at ambient temperature. The reaction mixture was filtered through a pad of celite, and the solvent was removed in vacuo. The residue was subjected to column chromatography (isohexanes/ethyl acetate 90:10), and the obtained crude product was used for the next step without further purification. To a cooled (0 °C) suspension of K2CO3 (0.090 g, 0.68 mmol) in methanol (5 mL), dimethyl (1-diazo-2-oxopropyl)phosphonate (Bestmann–Ohira reagent; 10% in acetonitrile, 1.2 mL, 0.51 mmol) was added under a nitrogen atmosphere, and the mixture was stirred for 5 min. The previously obtained crude aldehyde (0.15 g) was redissolved in dichloromethane (3 mL) and added dropwise. The mixture was allowed to warm to room temperature and stirred overnight. The saturated NH4Cl solution (1 mL) and water (8 mL) were added, and the biphasic mixture was extracted with dichloromethane (3 × 10 mL). The combined organic extracts were washed with brine (30 mL), and then dried using phase separation paper. After the solvent had been removed in vacuo, the crude product was subjected to column chromatography (isohexanes/ethyl acetate 98:2) to provide (24R,25RS)-26-ethynyl-6β-methoxy-26-nor-3α,5-cyclo-5α-stigmastane (15) (92 mg, 0.21 mmol, 28% over two steps) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 3.32 (s, 3H, OCH3), 2.77 (t, J = 2.9 Hz, 1H, H-6), 2.58 (td, J = 5.5, 2.4 Hz, 1H, H-25), 2.03–1.95 (m, 2H, H-12 and H-1′), 1.89 (dt, J = 13.7, 3.2 Hz, 1H, H-1), 1.86–1.55 (m, 4H), 1.53–1.04 (m, 20H), 1.02 (s, 3H, H-19), 0.96–0.75 (m, 10H), 0.72 (s, 3H, H-18), 0.67–0.62 (m, 1H, H-4), 0.43 (dd, J = 8.0, 5.0 Hz, 1H, H-4). 13C NMR (101 MHz, CDCl3) δ 88.7 and 88.3 (C, C-26), 82.6 (CH, C-6), 68.74 and 68.66 (CH, C-1′), 56.72 (CH3, OCH3), 56.7 (CH, C-14) 56.31 and 56.30 (CH, C-17), 48.2 (C-9), 44.9 and 44.8 (CH, C-24), 43.6 (C, C-19), 42.9 (C, C-13), 40.4 (CH2, C-12), 36.4 and 36.3 (CH, C-20), 35.5 (C, C-5), 35.2 (CH2, C-1), 33.8 (CH2, C-7), 33.5 and 33.4 (CH2, C-22), 30.6 (CH, C-8), 28.5 (CH2, C-16), 28.3 and 28.2 (CH, C-25), 27.3 (CH2, C-23), 26.6 (CH2, C-15), 25.1 (CH2, C-2), 24.4 and 24.3 (CH2, C-11), 23.3 and 22.9 (CH2, C-28), 21.7 (CH, C-3), 19.4 (CH3, C-19), 19.0 and 18.9 (CH3, C-21), 18.4 and 17.9 (CH3, C-27), 13.2 (CH2, C-4), 12.4 (CH3, C-18), 12.1 and 12.0 (CH3, C-29). HREIMS m/z 438.3856 (calcd for [C31H50O]•+, 438.3856).
(24R,25RS)-26-Ethynyl-26-norstigmast-5-ene-3β-ol, FB-DJ-1 (4)
(24R,25RS)-26-Ethynyl-6β-methoxy-26-nor-3α,5-cyclo-5α-stigmastane (15) (83 mg, 0.19 mmol) was dissolved in dioxane (3.5 mL) and water (0.50 mL), and p-toluenesulfonic acid (7.2 mg, 0.038 mmol) was added. The mixture was stirred at 80 °C for 30 min. After cooling to room temperature, the mixture was diluted with ethyl acetate (20 mL) and pyridine (0.75 mL) and washed with water (3 × 25 mL). After drying using phase separation paper, the solvent was evaporated, and the crude product was subjected to column chromatography (isohexanes/ethyl acetate 8:2) to provide (24R,25RS)-26-ethynyl-26-norstigmast-5-ene-3β-ol (4) (69 mg, 0.16 mmol, 86%) as a colorless solid. 1H NMR (500 MHz, CDCl3) δ 5.38–5.32 (m, 1H, H-6), 3.53 (dt, J = 14.9, 7.8 Hz, 1H, H-3), 2.58 (ddt, J = 7.0, 4.9, 2.5 Hz, 1H, H-25), 2.32–2.20 (m, 2H, H-4), 2.04–1.92 (m, 3H, H-7, H-12 and H-1′), 1.92–1.77 (m, 3H, H-1, H-2 and H-7), 1.54–0.88 (m, 30H, with s, 3H, H-19 underneath), 0.68 (s, 3H, H-18). 13C NMR (126 MHz, CDCl3) δ 140.9 (C, C-5), 121.9 (CH, C-6), 88.6 and 88.3 (C, C-26), 72.0 (CH, C-3), 68.8 and 68.7 (CH, C-1′), 56.9 (CH, C-14), 56.1 (CH, C-17), 50.3 (CH, C-9), 44.9 and 44.7 (CH, C-24), 42.48 (C, C-13), 42.46 (CH2, C-4), 39.9 (CH2, C-12), 37.4 (CH2, C-1), 36.7 (C, CH-10), 36.4 and 36.3 (CH, C-20), 33.8 and 33.4 (CH2, C-22), 32.1 (CH2, C-7), 31.8 (CH, C-8), 28.4 (CH2, C-2), 28.3 and 28.2 (CH, C-25), 27.3 (CH2, C-16), 26.5 (CH2, C-23), 24.5 and 24.3 (CH2, C-15), 23.3 (CH2, C-28), 21.2 (CH2, C-11), 19.6 (CH3, C-19), 19.0 and 18.9 (CH3, C-21), 18.3 and 17.9 (CH3, C-27), 12.1 (CH3, C-29), 12.01 and 11.98 (CH3, C-18). HREIMS m/z 424.3703 (calcd for [C30H48O]•+, 424.3700). m.p.: 116 °C. [α] = −25.8 ° (c = 0.16). Purity (HPLC): >99%.

3. Results

3.1. Synthesis Strategy

To synthesize the target compound FB-DJ-1 (4), there was a need for the construction of a Δ5-sterol with a side chain containing an ethyl branching at C-24 with exact and predictable 24R configuration, in combination with an alkyne moiety built up from one of the terminal methyl groups (C-26/C-27). This aim could not be achieved through a late-stage functionalization of sitosterol (2). The de novo enantioselective synthesis of complex steroids can only be achieved by means of complex multi-step procedures [27]. So, we intended to develop a synthetic approach which includes the assembly of the side chain at C-17 in a stereoselective manner, starting from an appropriately substituted steroidal precursor in the sense of a chiral pool synthesis [28,29], ideally utilizing asymmetric induction through existing stereocenters. Furthermore, the appropriate protection of the 3-OH and the Δ5 olefinic moiety had to be taken into consideration.
After the comprehensive analysis of published data in this field, we decided to utilize an approach, in which a crucial step is a Johnson–Claisen rearrangement, starting from an enantiopure steroidal side chain allylic alcohol and an orthocarboxylate, as described before by the groups of Djerassi [30] and Ikegawa [26], for the construction of the desired side chain. This procedure starts from a steroidal C-21 aldehyde (A), which is converted into a separable mixture of diastereomeric alkynols B1/B2 by the addition of a metallated terminal alkyne (here, 1-butyne). The obtained alkynols can optionally be reduced to the (E)- or (Z)-configured allylic alcohols C1/C2 via the use of a suitable reducing agent. From this point on, divergent routes should lead to branched side chains, including a terminal ester group, as potential precursors of the desired terminal alkyne. Notably, in this Johnson–Claisen rearrangement with triethyl orthopropionate, both a (22R)-configured alcohol with (Z)-geometry of the olefin (C1) and a (22S)-configured alcohol with (E)-geometry (C2) should provide products with identical (R)-configuration at C-24. Other than the configuration at C-24, the configuration at C-25 can not be fully controlled in this rearrangement; an epimeric mixture concerning C-25 was to be expected based on published data [28,29]. Finally, the ester group was to be converted into a terminal alkyne by means of reduction to the corresponding aldehyde, followed by alkyne synthesis utilizing the appropriate C1-building blocks (Figure 2).

3.2. Chemistry

As pointed out above, a suitably ring A/B-protected sterol with a truncated side chain (22-aldehyde) was required for this approach. We selected the commercially available sterol stigmasterol (5) as the starting material, since, after the appropriate protection of functional groups in the tetracyclic core, the Δ22 double bond can be cleaved via ozonolysis to give the required aldehyde building block 7. The protection of the 3-hydroxy group and the Δ5 olefinic moiety had to be resistant to all of the intended modifications in the side chain, including ozonolysis, organometallic chemistry, reductions, acid-mediated Johnson–Claisen rearrangement, and aldehyde-to-alkyne conversion. For this purpose, we identified the i-methyl ether 6 as the most promising intermediate, since it includes the protection of both the 3-OH and the Δ5 olefinic moiety and shows high stability, but also allows for the easy regeneration of intact ring A/B functionalities via treatment with acids. Intermediate 6 was obtained from stigmasterol (5) following a published protocol, and the subsequent ozonolysis of the Δ22 olefin produced aldehyde 7 in an acceptable yield [31] (Scheme 1).
In the next step, 1-metalated 1-butyne was to be added to the aldehyde 7 in order to obtain the alkynol intermediates of type B1/B2 (Figure 1). In previous works in this field, this nucleophilic addition was performed by using 1-butyne (boiling point: 8 °C) after the conversion of the terminal alkyne moiety into the corresponding bromomagnesium [26,30] or lithium salts [25]. But, since 1-butyne is commercially available only in a gaseous form in steel bottles, and the handling of this compound bears severe risks due to its explosiveness [32], we intended to avoid using this hazardous compound. So, we chose to utilize 1-trimethylsilyl-1-butyne (8), a commercially available, easy-to-handle liquid, as the precursor for a 1-metalated 1-butyne. A limited number of publications describe in situ generations of acetylides from 1-trimethylsilylalkynes and fluoride sources, followed by additions to aldehydes or ketones. In situ desilylation was accomplished by means of fluoride sources, like tetrabutylammonium fluoride (TBAF) [33,34] and cesium fluoride [35], the latter in some cases promoted by the addition of a crown ether [36,37]. In fact, aldehyde 7, upon treatment with 1-trimethylsilyl-1-butyne (8) and catalytic amounts of TBAF, provided a diastereomeric mixture of alkynols (9a/9b), which was, as published [25,26,30], separable on a preparative scale via the use of flash column chromatography on silica gel. The best yields (35% for the 22S-enantioner 9b, 19% for the 22R-enantiomer 9a) were obtained via four equivalents of the alkyne building block and very slow addition to the aldehyde solution. These yields are in the same range as obtained by means of the addition of 1-butyne building blocks, obtained via the direct metalation of the alkyne [25,30].
As pointed out above, both diastereomers (9a with 22R configuration and 9b with 22S configuration) should open the option for synthesizing the 24R-configured target compound by means of a Johnson–Claisen rearrangement. For this purpose, 9a (22R) needed to be reduced in a stereoselective manner to the Z-olefin 10a, whereas 9b (22S) was to be converted into the E-olefin 10b. Both of these reductions were conveniently achieved following published protocols as follows: Z-configured allylic alcohol 10a was obtained (56% yield) via the reduction of 9a by means of hydrogenation with Lindlar’s catalyst [31], and E-configured product 10b was obtained in 72% yield via the lithium alanate reduction of 9b [28].
The construction of C24-branched sterols from side chain allylic alcohols has been the subject of previous investigations, and the hydroxy group at C-22 offers, via derivatization with activated carboxylic acids, a central step. The previous work of Horibe et al. [38] included esterification and subsequent transformation into ester silylenol derivatives, followed by the rearrangement. However, this reaction affords the cancerogenic solvent HMPA, and thus is not practicable nowadays. A convenient alternative was formulated by Djerassi [28], who exploited the direct conversion of allylic alcohols with orthocaboxylates. Following this and other related protocols [26] with some modifications, alcohols 10a/10b were treated with triethyl orthopropinate/propionic acid in refluxing xylene.
To our surprise, and in contrast to published data [26,38], the Z-configured alcohol 10a, upon treatment with triethyl orthopropionate, provided a complex mixture of stereoisomeric products (evident from additional resonances in the NMR spectra when compared to the sample obtained from 10b), from which the target product could not be isolated. Fortunately, the E-configured alcohol 10b reacted readily with triethyl orthopropionate/propionic acid in the manner of a Johnson–Claisen rearrangement to give ester 11 in a 78% yield. As expected from the published data, we obtained a mixture of epimers, since no stereocontrol was obtained for C-25. The epimeric esters 11 were not separable on a preparative scale, and represent (based on 13C-NMR data; see Supplementary Materials) about a 1:1 mixture.
The reduction of the Δ22 double bond in 11 to give ester 12 was easily achieved via catalytic hydrogenation using Pd on the charcoal catalyst [26], providing saturated derivative 12 in a 88% yield. In the final and unprecedented step, the ester group of 12 had to be converted into a terminal alkyne. This was accomplished in three steps, starting with the reduction of the ester moiety to a primary alcohol 13 with lithium alanate (96% yield). The subsequent controlled oxidation of 13 to the aldehyde 14 was first attempted with Dess–Martin periodinane [39], but resulted in a disappointing yield (24%). In contrast, oxidation with PCC (pyridinium chlorochromate) [40] led to clean and complete conversion within 4 h; however, aldehyde 14 turned out to decompose rapidly. Consequently, we only performed a very short chromatographic preliminary purification, and subjected the obtained product directly to a Bestmann–Ohira reaction [41] in order to obtain the alkyne 15 in a 28% yield over two steps. In the final step, both the 3-OH and the Δ5 moieties were regenerated from the steroid i-methyl ether in an 86% yield via the treatment with p-toluenesulfonic acid in dioxane. The obtained target compound FB-DJ-1 (4) was, as expected, about a 1:1 mixture of epimers at C-25; neither this compound nor the precursors (12, 13, 15) were separable via chromatography on a preparative scale (Scheme 1).

4. Discussion

For an in-depth investigation of the localization and biological functions of phytosterols, there is an urgent need for phytosterol-based chemical tools, which show, on the one hand, close structural similarity to the physiological sterols, but, on the other hand, offer options for derivatization with fluorescent dyes by means of click chemistry for highly sensitive fluorescence imaging. Based on published methods utilizing the Johnson–Claisen rearrangement for the construction of branched sterol side chains, and with major novel methodologic input, we formulated the synthesis of the promising alkyne-derived sitosterol FB-DJ-1 (4) for future investigations of plants. This new chemical probe is at present under investigation (in combination with novel azide dyes) in the lab of our cooperative partners for imaging experiments in diverse plants.
Moreover, the synthesis protocol described here offers the opportunity for preparing related interesting phytosterol-derived chemical probes. For instance, maintaining the Δ22 double bond (see intermediate 11) would lead to clickable alkyne derivatives of stigmasterol (5), and, with slight modifications, alkyne derivatives of 24S-configured algal sterols (e.g., clionasterol (3)) should be available. Furthermore, the 26-hydroxy intermediate 13 could alternatively be converted into an azide, providing complementary clickable chemical tools, as compared to the alkyne 4 and analogues discussed before.
Thus, we are confident that the chemical approach we present here will open doors for future comprehensive imaging experiments in the field in phytosterols.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/biom14050542/s1, NMR spectra of all synthesized compounds.

Author Contributions

Conceptualization, F.B.; methodology, F.B.; investigation, M.H. and D.J.; resources, F.B.; data curation, M.H. and D.J.; writing—original draft preparation, F.B. and M.H.; writing—review and editing, F.B. and M.H.; visualization, M.H.; supervision, F.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Detailed data are available upon request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Schade, D.S.; Shey, L.; Eaton, R.P. Cholesterol Review: A Metabolically Important Molecule. Endocr. Pract. 2020, 26, 1514–1523. [Google Scholar] [CrossRef] [PubMed]
  2. Müller, C.; Binder, U.; Bracher, F.; Giera, M. Antifungal drug testing by combining minimal inhibitory concentration testing with target identification by gas chromatography-mass spectrometry. Nat. Protoc. 2017, 12, 947–963. [Google Scholar] [CrossRef] [PubMed]
  3. Nattagh-Eshtivani, E.; Barghchi, H.; Pahlavani, N.; Barati, M.; Amiri, Y.; Fadel, A.; Khosravi, M.; Talebi, S.; Arzhang, P.; Ziaei, R.; et al. Biological and pharmacological effects and nutritional impact of phytosterols: A comprehensive review. Phytother. Res. 2022, 36, 299–322. [Google Scholar] [CrossRef] [PubMed]
  4. Liu, B.; Chen, K.; Chen, X.; Wang, J.; Shu, G.; Ping, Z.; Zhang, S. Health outcomes associated with phytosterols: An umbrella review of systematic reviews and meta-analyses of randomized controlled trials. Phytomedicine 2024, 122, 155151. [Google Scholar] [CrossRef] [PubMed]
  5. Jao, C.Y.; Nedelcu, D.; Lopez, L.V.; Samarakoon, T.N.; Welti, R.; Salic, A. Bioorthogonal probes for imaging sterols in cells. ChemBiochem 2015, 16, 611–617. [Google Scholar] [CrossRef]
  6. Kolb, H.C.; Finn, M.G.; Sharpless, K.B. Click Chemistry: Diverse Chemical Function from a Few Good Reactions. Angew. Chem. Int. Ed. 2001, 40, 2004–2021. [Google Scholar] [CrossRef]
  7. Sletten, E.M.; Bertozzi, C.R. From Mechanism to Mouse: A Tale of Two Bioorthogonal Reactions. Acc. Chem. Res. 2011, 44, 666–676. [Google Scholar] [CrossRef]
  8. Sletten, E.M.; Bertozzi, C.R. Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality. Angew. Chem. Int. Ed. 2009, 48, 6974–6998. [Google Scholar] [CrossRef]
  9. Kacprzak, K.; Skiera, I.; Piasecka, M.; Paryzek, Z. Alkaloids and Isoprenoids Modification by Copper(I)-Catalyzed Huisgen 1,3-Dipolar Cycloaddition (Click Chemistry): Toward New Functions and Molecular Architectures. Chem. Rev. 2016, 116, 5689–5743. [Google Scholar] [CrossRef]
  10. Zhang, X.; Zhang, S.; Zhao, S.; Wang, X.; Liu, B.; Xu, H. Click Chemistry in Natural Product Modification. Front. Chem. 2021, 9, 774977. [Google Scholar] [CrossRef]
  11. Hu, J.; Lu, J.R.; Ju, Y. Steroid/triterpenoid functional molecules based on “click chemistry”. Chem. Asian J. 2011, 6, 2636–2647. [Google Scholar] [CrossRef]
  12. Chauhan, N.; Sere, Y.Y.; Sokol, A.M.; Graumann, J.; Menon, A.K. A PhotoClick cholesterol-based quantitative proteomics screen for cytoplasmic sterol-binding proteins in Saccharomyces cerevisiae. Yeast 2020, 37, 15–25. [Google Scholar] [CrossRef]
  13. Tallman, K.A.; Kim, H.H.; Korade, Z.; Genaro-Mattos, T.C.; Wages, P.A.; Liu, W.; Porter, N.A. Probes for protein adduction in cholesterol biosynthesis disorders: Alkynyl lanosterol as a viable sterol precursor. Redox Biol. 2017, 12, 182–190. [Google Scholar] [CrossRef]
  14. Windsor, K.; Genaro-Mattos, T.C.; Kim, H.-Y.H.; Liu, W.; Tallman, K.A.; Miyamoto, S.; Korade, Z.; Porter, N.A. Probing lipid-protein adduction with alkynyl surrogates: Application to Smith-Lemli-Opitz syndrome. J. Lipid Res. 2013, 54, 2842–2850. [Google Scholar] [CrossRef]
  15. Hofmann, K.; Thiele, C.; Schött, H.F.; Gaebler, A.; Schoene, M.; Kiver, Y.; Friedrichs, S.; Lütjohann, D.; Kuerschner, L. A novel alkyne cholesterol to trace cellular cholesterol metabolism and localization. J. Lipid Res. 2014, 55, 583–591. [Google Scholar] [CrossRef]
  16. Seck, I.; Fall, A.; Lago, C.; Sène, M.; Gaye, M.; Seck, M.; Gómez, G.; Fall, Y. Synthesis of a Cholesterol Side-Chain Triazole Analogue via ‘Click’ Chemistry. Synthesis 2015, 47, 2826–2830. [Google Scholar] [CrossRef]
  17. Xiao, X.; Tang, J.J.; Peng, C.; Wang, Y.; Fu, L.; Qiu, Z.P.; Xiong, Y.; Yang, L.F.; Cui, H.W.; He, X.L.; et al. Cholesterol Modification of Smoothened Is Required for Hedgehog Signaling. Mol. Cell 2017, 66, 154–162.e10. [Google Scholar] [CrossRef]
  18. Sheng, R.; Luo, T.; Li, H.; Sun, J.; Wang, Z.; Cao, A. ‘Click’ synthesized sterol-based cationic lipids as gene carriers, and the effect of skeletons and headgroups on gene delivery. Bioorg. Med. Chem. 2013, 21, 6366–6377. [Google Scholar] [CrossRef]
  19. Hajdaś, G.; Kawka, A.; Koenig, H.; Kułaga, D.; Sosnowska, K.; Mrówczyńska, L.; Pospieszny, T. Click chemistry as a method for the synthesis of steroid bioconjugates of bile acids derivatives and sterols. Steroids 2023, 199, 109282. [Google Scholar] [CrossRef]
  20. Kawka, A.; Hajdaś, G.; Kułaga, D.; Koenig, H.; Kowalczyk, I.; Pospieszny, T. Molecular structure, spectral and theoretical study of new type bile acid–sterol conjugates linked via 1,2,3-triazole ring. J. Mol. Struct. 2023, 1273, 134313. [Google Scholar] [CrossRef]
  21. Darnet, S.; Blary, A.; Chevalier, Q.; Schaller, H. Phytosterol Profiles, Genomes and Enzymes—An Overview. Front. Plant Sci. 2021, 12, 665206. [Google Scholar] [CrossRef]
  22. Lomenick, B.; Shi, H.; Huang, J.; Chen, C. Identification and characterization of β-sitosterol target proteins. Bioorg. Med. Chem. Lett. 2015, 25, 4976–4979. [Google Scholar] [CrossRef]
  23. Yuan, J.-W.; Qu, L.-B. Efficient synthesis of novel β-sitosterol scaffolds containing 1,2,3-triazole via copper(I)-catalyzed click reaction under microwave irradiation. Z. Naturforsch. B 2017, 72, 717–724. [Google Scholar] [CrossRef]
  24. Ilkar Erdagi, S.; Uyanik, C. Biological evaluation of bioavailable amphiphilic polymeric conjugate based-on natural products: Diosgenin and curcumin. Int. J. Polym. Mater. Polym. Biomat. 2020, 69, 73–84. [Google Scholar] [CrossRef]
  25. Chapelon, A.-S.; Moraléda, D.; Rodriguez, R.; Ollivier, C.; Santelli, M. Enantioselective synthesis of steroids. Tetrahedron 2007, 63, 11511–11616. [Google Scholar] [CrossRef]
  26. Brill, Z.G.; Condakes, M.L.; Ting, C.P.; Maimone, T.J. Navigating the Chiral Pool in the Total Synthesis of Complex Terpene Natural Products. Chem. Rev. 2017, 117, 11753–11795. [Google Scholar] [CrossRef]
  27. Jastrzębska, I.; Covey, D.F. Chiral Building Blocks for Total Steroid Synthesis and the Use of Steroids as Chiral Building Blocks in Organic Synthesis. In Chiral Building Blocks in Asymmetric Synthesis; John Wiley & Sons: Hoboken, NJ, USA, 2022; pp. 367–387. [Google Scholar] [CrossRef]
  28. Wiersig, J.R.; Waespe-Sarcevic, N.; Djerassi, C. Stereospecific synthesis of the side chain of the steroidal plant sex hormone oogoniol. J. Org. Chem. 1979, 44, 3374–3382. [Google Scholar] [CrossRef]
  29. Fujimoto, Y.; Kimura, M.; Khalifa, F.M.; Ikekawa, N. Side Chain Structural Requirement for Utilization of Sterols by the Silkworm for Growth and Development. Non-stereoselective Utilization of the 24-Stereoisomeric Pairs of 24-Alkylsterols. Chem. Pharm. Bull. 1984, 32, 4372–4381. [Google Scholar] [CrossRef]
  30. Partridge, J.J.; Faber, S.; Uskoković, M.R. Vitamin D3 metabolites. I. Synthesis of 25-hydroxycholesterol. Helv. Chim. Acta 1974, 57, 764–771. [Google Scholar] [CrossRef]
  31. Litvinovskaya, R.P.; Raiman, M.E.; Khripach, V.A. Synthesis of 28-homobrassinosteroids modified in the 26-position. Chem. Nat. Comp. 2009, 45, 647–652. [Google Scholar] [CrossRef]
  32. National Center for Biotechnology Information. PubChem Compound Summary for CID 7846, 1-Butyne. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/1-Butyne (accessed on 12 February 2024).
  33. Nakamura, E.; Kuwajima, I. Fluoride Catalyzed Addition of Silylacetylenes to Carbonyl Compounds. Angew. Chem. Int. Ed. 1976, 15, 498–499. [Google Scholar] [CrossRef]
  34. Capani, J.S., Jr.; Cochran, J.E.; Liang, J. CsF-Mediated in Situ Desilylation of TMS-Alkynes for Sonogashira Reaction. J. Org. Chem. 2019, 84, 9378–9384. [Google Scholar] [CrossRef] [PubMed]
  35. Wender, P.A.; Zercher, C.K. Studies on DNA-cleaving agents: Synthesis of a functional dynemicin analogue. J. Am. Chem. Soc. 1991, 113, 2311–2313. [Google Scholar] [CrossRef]
  36. Nishikawa, T.; Ino, A.; Isobe, M.; Goto, T. Synthesis of a Simple Model Compound of Dynemicin and Cycloaromatization with Pinacol-Pinacolone Rearrangement in the Strained Enediyne Medium Ring. Chem. Lett. 2006, 20, 1271–1274. [Google Scholar] [CrossRef]
  37. Nishikawa, T.; Yoshikai, M.; Obi, K.; Isobe, M. Synthesis of both enantiomers of dynemicin a model compound. New remote asymmetric induction in acetylide addition into quinoline nucleus as key step. Tetrahedron Lett. 1994, 35, 7997–8000. [Google Scholar] [CrossRef]
  38. Horibe, I.; Nakai, H.; Sato, T.; Seo, S.; Takeda, K.i.; Takatsuto, S. Stereoselective synthesis of the C-24 and C-25 stereoisomeric pairs of 24-ethyl-26-hydroxy- and 24-ethyl-[26-2H]sterols and their Δ22-derivatives: Reassignment of 13C n.m.r. signals of the pro-R and the pro-S methyl groups at C-25 of 24-ethylsterols. J. Chem. Soc. Perkin Trans. 1989, 1, 1957–1967. [Google Scholar] [CrossRef]
  39. Dess, D.B.; Martin, J.C. Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones. J. Org. Chem. 1983, 48, 4155–4156. [Google Scholar] [CrossRef]
  40. Ohyama, K.; Kushiro, T.; Nakamura, K.; Fujimoto, Y. Biosynthesis of 20-hydroxyecdysone in Ajuga hairy roots: Fate of 6α- and 6β-hydrogens of lathosterol. Bioorg. Med. Chem. 1999, 7, 2925–2930. [Google Scholar] [CrossRef]
  41. Suto, T.; Yanagita, Y.; Nagashima, Y.; Takikawa, S.; Kurosu, Y.; Matsuo, N.; Sato, T.; Chida, N. Unified Total Synthesis of Madangamines A, C, and E. J. Am. Chem. Soc. 2017, 139, 2952–2955. [Google Scholar] [CrossRef]
Biomolecules 14 00542 g001
Figure 1. Structures of cholesterol (1), sitosterol (2), clionasterol (3), and the clickable target compound FB-DJ-1 (4).
Figure 1. Structures of cholesterol (1), sitosterol (2), clionasterol (3), and the clickable target compound FB-DJ-1 (4).
Biomolecules 14 00542 g001
Biomolecules 14 00542 g002
Figure 2. Envisaged synthesis route to the target compound FB-DJ-1 (4).
Figure 2. Envisaged synthesis route to the target compound FB-DJ-1 (4).
Biomolecules 14 00542 g002
Biomolecules 14 00542 sch001
Scheme 1. Synthesis of the target compound FB-DJ-1 (4).
Scheme 1. Synthesis of the target compound FB-DJ-1 (4).
Biomolecules 14 00542 sch001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hollweck, M.; Jordan, D.; Bracher, F. Synthesis of a Side Chain Alkyne Analogue of Sitosterol as a Chemical Probe for Imaging in Plant Cells. Biomolecules 2024, 14, 542. https://doi.org/10.3390/biom14050542

AMA Style

Hollweck M, Jordan D, Bracher F. Synthesis of a Side Chain Alkyne Analogue of Sitosterol as a Chemical Probe for Imaging in Plant Cells. Biomolecules. 2024; 14(5):542. https://doi.org/10.3390/biom14050542

Chicago/Turabian Style

Hollweck, Miriam, David Jordan, and Franz Bracher. 2024. "Synthesis of a Side Chain Alkyne Analogue of Sitosterol as a Chemical Probe for Imaging in Plant Cells" Biomolecules 14, no. 5: 542. https://doi.org/10.3390/biom14050542

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop